(Q38333228)

English

Inhibition of VEGF receptors significantly impairs mammary cancer growth in C3(1)/Tag transgenic mice through antiangiogenic and non-antiangiogenic mechanisms

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

2 September 2017

Inhibition of VEGF receptors significantly impairs mammary cancer growth in C3(1)/Tag transgenic mice through antiangiogenic and non-antiangiogenic mechanisms (English)

1 reference

Europe PubMed Central

PubMed publication ID

2 September 2017

angiogenesis inhibitor

1 reference

based on heuristic

inferred from title

author name string

Jung-Im Huh

1

1 reference

Europe PubMed Central

PubMed publication ID

2 September 2017

Alfonso Calvo

2

1 reference

Europe PubMed Central

PubMed publication ID

2 September 2017

Jeffrey Stafford

3

1 reference

Europe PubMed Central

PubMed publication ID

2 September 2017

Mui Cheung

4

1 reference

Europe PubMed Central

PubMed publication ID

2 September 2017

Rakesh Kumar

5

1 reference

Europe PubMed Central

PubMed publication ID

2 September 2017

Deborah Philp

6

1 reference

Europe PubMed Central

PubMed publication ID

2 September 2017

Hynda K Kleinman

7

1 reference

Europe PubMed Central

PubMed publication ID

2 September 2017

Jeffrey E Green

8

1 reference

Europe PubMed Central

PubMed publication ID

2 September 2017

language of work or name

0 references

publication date

1 January 2005

1 reference

Europe PubMed Central

PubMed publication ID

2 September 2017

1 reference

Europe PubMed Central

PubMed publication ID

2 September 2017

24

1 reference

Europe PubMed Central

PubMed publication ID

2 September 2017

5

1 reference

Europe PubMed Central

PubMed publication ID

2 September 2017

790-800

1 reference

Europe PubMed Central

PubMed publication ID

2 September 2017

https://scigraph.springernature.com/pub.10.1038/sj.onc.1208221

0 references

Inhibition of the mammary carcinoma angiogenic switch in C3(1)/SV40 transgenic mice by a mutated form of human endostatin.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1208221

21 January 2018

Anti-epidermal growth factor receptor drugs in cancer therapy

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1208221

21 January 2018

Angiogenesis in cancer, vascular, rheumatoid and other disease

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1208221

21 January 2018

Blood vessel formation: what is its molecular basis?

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1208221

21 January 2018

Role of the Flt-1 receptor tyrosine kinase in regulating the assembly of vascular endothelium

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1208221

21 January 2018

VEGF-Trap: a VEGF blocker with potent antitumor effects

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1208221

21 January 2018

Development and characterization of a progressive series of mammary adenocarcinoma cell lines derived from the C3(1)/SV40 Large T-antigen transgenic mouse model

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1208221

21 January 2018

Synthesis of Antihemophilic Factor Antigen by Cultured Human Endothelial Cells

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1208221

21 January 2018

Clinical translation of angiogenesis inhibitors

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1208221

21 January 2018

Prostate and mammary adenocarcinoma in transgenic mice carrying a rat C3(1) simian virus 40 large tumor antigen fusion gene

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1208221

21 January 2018

Bioactivity of anti-angiogenic ribozymes targeting Flt-1 and KDR mRNA.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1208221

21 January 2018

GW654652, the pan-inhibitor of VEGF receptors, blocks the growth and migration of multiple myeloma cells in the bone marrow microenvironment

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1208221

21 January 2018

An angiogenic laminin site and its antagonist bind through the alpha(v)beta3 and alpha5beta1 integrins.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1208221

21 January 2018

2-Methoxyestradiol: an endogenous antiangiogenic and antiproliferative drug candidate

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1208221

21 January 2018

2-Methoxyestradiol induces mitochondria dependent apoptotic signaling in pancreatic cancer cells

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1208221

21 January 2018

Failure of blood-island formation and vasculogenesis in Flk-1-deficient mice

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1208221

21 January 2018

Smart drugs: tyrosine kinase inhibitors in cancer therapy

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1208221

21 January 2018

The protein tyrosine kinase inhibitor SU5614 inhibits VEGF-induced endothelial cell sprouting and induces growth arrest and apoptosis by inhibition of c-kit in AML cells

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1208221

21 January 2018

A single autophosphorylation site on KDR/Flk-1 is essential for VEGF-A-dependent activation of PLC-gamma and DNA synthesis in vascular endothelial cells

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1208221

21 January 2018

Tyrosine kinases as targets in cancer therapy - successes and failures

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1208221

21 January 2018

Co-expression of vascular endothelial growth factor (VEGF) and its receptors (flk-1 and flt-1) in hormone-induced mammary cancer in the Noble rat

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1208221

21 January 2018

Inhibition of human leukemia in an animal model with human antibodies directed against vascular endothelial growth factor receptor 2. Correlation between antibody affinity and biological activity

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1208221

21 January 2018

Identifiers

10.1038/SJ.ONC.1208221

1 reference

Europe PubMed Central

PubMed publication ID

2 September 2017

Dimensions Publication ID

0 references

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

2 September 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q38333228&oldid=1753772962"